ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

I now have solid data to write the article. Let me compile the key names by market cap, day-by-day.

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

I now have solid data to write the article. Let me compile the key names by market cap, day-by-day.

Earnings Blitz: 1,800 Companies Report

A packed week kicks off with Monday's confirmed releases. Corebridge Financial ($13B) drops results after the close. Auto parts firm Alamo Group also reports Monday. Pharma name BioMarin Pharmaceutical hosts its earnings call that evening.

Tuesday brings Irish biopharma Alkermes to the stand. The $5.6B company reports before the open. Childcare operator Bright Horizons Family Solutions follows with its release at day's end.

The week's biggest confirmed US name hits on Wednesday. Drug distributor Cencora — market cap near $60B — holds its earnings call at 8:30 AM ET. Auto supplier Flex ($33B) also reports Wednesday morning. Lithium major Albemarle ($23B) and investment bank Houlihan Lokey close out the session after the bell.

Thursday sees CDN giant Akamai Technologies ($15B) report after hours. Engineering software firm Bentley Systems posts before the open alongside cell therapy play Vericel.

BorgWarner and Cirrus Logic also feature mid-week. The broader market — with over 1,800 companies reporting — faces a critical test of tariff and margin resilience.

No IPOs are confirmed in the pipeline for the next seven days.

How this article was generated

Generated
2 May 2026, 00:31
Prompt version
migrated
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.